<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-INR-16009871</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2016-11-16</date_registration>
      <primary_sponsor>Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine</primary_sponsor>
      <public_title>A randomized controlled clinical trial of rapidly prepared bioactive materials as bone graft using bone marrow stem cells screen-and-enrich-and-combine(-biomaterials) circulating system(SECCS) versus autologous bone graft for bone regeneration</public_title>
      <acronym />
      <scientific_title>A randomized controlled clinical trial of rapidly prepared bioactive materials as bone graft using bone marrow stem cells screen-and-enrich-and-combine(-biomaterials) circulating system(SECCS) versus autologous bone graft for bone regeneration</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2016-11-25</date_enrolment>
      <type_enrolment />
      <target_size>treatment group:82;controlled group:82;</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=16813</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>bone defect and bone non-union</hc_freetext>
      <i_freetext>treatment group:rapidly prepared bioactive materials as bone graft using bone marrow stem cells screen-and-enrich-and-combine(-biomaterials) circulating system(SECCS);controlled group:autologous bone graft;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Xin Wang</firstname>
        <middlename />
        <lastname />
        <address>639 Zhizaoju Road, Shanghai, China</address>
        <city />
        <country1 />
        <zip>200011</zip>
        <telephone>+86 15921963129</telephone>
        <email>walsheim@163.com</email>
        <affiliation>Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>YaoKai Gan</firstname>
        <middlename />
        <lastname />
        <address>639 Zhizaoju Road, Shanghai, China</address>
        <city />
        <country1 />
        <zip>200011</zip>
        <telephone>+86 15021317328</telephone>
        <email>ganyk2004@126.com</email>
        <affiliation>Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Aged 15 to 65 years male and female;
2. patients require bone grafting including:
(1) bone defect which need less than 15ml bone grafts;
(2) bone non-union or delayed union;
(3) spinal operation needing 5~60ml bone grafts;
3. Be willing sign the informed consent.</inclusion_criteria>
      <agemin>15</agemin>
      <agemax>65</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. malignant tumor;
2. myelodysplastic syndrome;
3. infected disease;
4. high dose chemoradiotherapy;
5. blood system disease;
6. operation site with infection or Hemoculture positive recently;
7. Hb＜7g/dl or severe coagulation disorders such as PT&gt;10 seconds and platelet less than 60×10^9/L
8. pregnant woman;
9. patients with decompensated cirrhosis,uremia or severe brain trauma;
10. patient paticipating in other clinial trials in the same time.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>union rate;clinical union time;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>bone callus amout;incidence rate of complication;enrichment rate of stem cells;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Clinical Research Plan of SHDC</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-11-11</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>